1. Home
  2. NNNN vs PLUS Comparison

NNNN vs PLUS Comparison

Compare NNNN & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • PLUS
  • Stock Information
  • Founded
  • NNNN 2021
  • PLUS 1990
  • Country
  • NNNN Germany
  • PLUS United States
  • Employees
  • NNNN N/A
  • PLUS N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PLUS Retail: Computer Software & Peripheral Equipment
  • Sector
  • NNNN Health Care
  • PLUS Technology
  • Exchange
  • NNNN Nasdaq
  • PLUS Nasdaq
  • Market Cap
  • NNNN 2.2B
  • PLUS 2.0B
  • IPO Year
  • NNNN 2025
  • PLUS 1996
  • Fundamental
  • Price
  • NNNN $23.92
  • PLUS $73.88
  • Analyst Decision
  • NNNN
  • PLUS
  • Analyst Count
  • NNNN 0
  • PLUS 0
  • Target Price
  • NNNN N/A
  • PLUS N/A
  • AVG Volume (30 Days)
  • NNNN 76.5K
  • PLUS 143.5K
  • Earning Date
  • NNNN 11-07-2025
  • PLUS 11-11-2025
  • Dividend Yield
  • NNNN N/A
  • PLUS 1.34%
  • EPS Growth
  • NNNN N/A
  • PLUS 9.38
  • EPS
  • NNNN 0.06
  • PLUS 4.46
  • Revenue
  • NNNN $8,185,146.00
  • PLUS $2,170,452,000.00
  • Revenue This Year
  • NNNN N/A
  • PLUS $7.12
  • Revenue Next Year
  • NNNN N/A
  • PLUS N/A
  • P/E Ratio
  • NNNN $442.46
  • PLUS $17.71
  • Revenue Growth
  • NNNN 21.95
  • PLUS N/A
  • 52 Week Low
  • NNNN $5.18
  • PLUS $53.83
  • 52 Week High
  • NNNN $55.65
  • PLUS $106.98
  • Technical
  • Relative Strength Index (RSI)
  • NNNN 35.64
  • PLUS 54.30
  • Support Level
  • NNNN $26.05
  • PLUS $70.75
  • Resistance Level
  • NNNN $30.65
  • PLUS $75.31
  • Average True Range (ATR)
  • NNNN 2.72
  • PLUS 1.91
  • MACD
  • NNNN -0.11
  • PLUS 0.18
  • Stochastic Oscillator
  • NNNN 19.80
  • PLUS 76.07

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

Share on Social Networks: